NIFTY 50

Sun Pharma replaces formulations distributor with own unit

Updated : January 22, 2019 11:32 AM IST

The company had last week asked capital market regulator Securities and Exchange Board of India (SEBI) to look into a media report about an alleged complaint by a whistleblower relating to certain transactions involving the company and its co-promoter that had led to a sell-off in the company's shares.
The drugmaker also denied giving any loans or guarantees to Suraksha Realty, adding that it does not have any financial deals with the Mumbai-based company.

You May Also Like

Live TV